4Filed Sep 17, 8:00 PM ET

Hims & Hers (HIMS) CFO Okupe Oluyemi Sells 12,313 Shares

$HIMS · Hims & Hers Health, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Hims & Hers (HIMS) CFO Okupe Oluyemi Sells 12,313 Shares

What Happened

Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), sold 12,313 shares on September 17, 2026 at $28.82 per share, generating proceeds of $354,861. The sale was reported on a Form 4 filed September 18, 2026. This was a sale (not a purchase); such sales are often routine and can be pre-arranged rather than a direct reflection of the insider's view on the company.

Key Details

  • Transaction date and price: 2026-09-17 — 12,313 shares sold at $28.82 each.
  • Total proceeds: $354,861.
  • Shares owned after transaction: Not reported in the provided filing.
  • Footnote: Sale was effected pursuant to a Rule 10b5-1 trading plan adopted May 20, 2026 (pre-arranged trading plan).
  • Timeliness: Form 4 filed on 2026-09-18 for the 09-17 transaction (appears timely).

Context

A Rule 10b5-1 plan allows insiders to set up predetermined trades, which can make sales appear routine and less indicative of new, private information. For retail investors, purchases generally carry more weight as a bullish signal; a single sale under a 10b5-1 plan should be interpreted cautiously and in the context of other insider activity and company fundamentals.